Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:59 PM
Ignite Modification Date:
2025-12-24 @ 10:59 PM
NCT ID:
NCT00925769
Eligibility Criteria:
Inclusion Criteria:
* adult patients, \>=18 years of age;
* pancreatic cancer with locally advanced and/or metastatic disease (stage IV);
* chemonaive for metastatic or locally advanced disease;
* ECOG performance status of 0-2.
Exclusion Criteria:
* local (stage IA to IIB)and locally advanced (stage III) pancreatic cancer;
* previous exposure to Avastin, Tarceva or Xeloda;
* other primary tumor within the last 5 years prior to enrollment, except for adequately treated cancer in situ of cervix, or basal cell skin cancer;
* current or recent chronic use of aspirin (\>325 mg/day) or full therapeutic dose of anticoagulants or thrombolytic agents.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00925769
Study Brief:
Protocol Section:
NCT00925769